LRRK2 and Parkinson disease: However, the proportion of mutated subjects in older patients is non-negligible (8.5%), especially for dominant genes such as GBA1 and LRRK2, having implications for family counseling and disease management, so the ideal goal would be to offer genetic testing to all PD patients at the time of diagnosis.